Select Publications
Reports
2009, The diversion and injection of the pharmaceutical opioids used in opiod substitution treatment (OST): Findings from the Australian post-marketing surveillance studies of buprenorphine-naloxone 2006-2008, National Drug and Alcohol Research Centre, Sydney, NSW, 302, http://ndarc.med.unsw.edu.au/resource/diversion-and-injection-pharmaceutical-opioids-used-opioid-substitution-treatment-findings
,2008, Qualitative Field Study for Users of Performance and Image Enhancing Drug, Drug and Alcohol Services South Australia, Adelaide
,2007, Benefits and risks of pharmaceutical opioids: Essential treatment and diverted medication. A global review of availability, extra-medical use, injection and the association with HIV., Sydney: National Drug and Alcohol Research Centre, University of NSW., Sydney, 2/2007, http://ndarc.med.unsw.edu.au/resource/benefits-and-risks-pharmaceutical-opioids-essential-treatment-and-diverted-medication
,2007, Performance and image enhancing drugs (PIEDs): Current trends and future monitoring., Sydney: National Drug and Alcohol Research Centre, University of New South Wales, Sydney, June 2007
,2006, The extent of diversion of fentanyl for non-medical purposes in Australia: What do we know?, National Drug and Alcohol Research Centre, University of New South Wales,, Sydney, 265
,2005, Mental Health, Drug use and risk among female street-based sex workers in Greater Sydney, National Drug & Alcohol Research Centre, Randwick, NSW
,2005, Rapid assessment of performance and image enhancing drugs (PIEDs) in New South Wales: Feasibility study 2005, National Drug & Alcohol Research Centre, Randwick, NSW, 239
,2005, Use of performance and image enhancing drugs among men: A review, National Drug & Alcohol Research Centre, Randwick, NSW
,